Kevin P. Delaney

2.8k citations

91 papers · 1.8k indexed · h-index 21

Co-authors: S. Michele Owen Elizabeth DiNenno Laura G. Wesolowski Bernard M. Branson Pollyanna R. Chávez Joseph Prejean Marc A. Pitasi Amy Lansky
Topics: HIV/AIDS Research and Interventions (69 papers)HIV, Drug Use, Sexual Risk (43 papers)HIV Research and Treatment (42 papers)
Cited by: Virology Infectious Diseases Epidemiology
Journals: SHILAP Revista de lepidopterologíaPLoS ONE Clinical Infectious Diseases
Partner nations: United States Uganda Kenya

In The Last Decade

Kevin P. Delaney

80 papers receiving 1.7k citations

Peers

Countries citing papers authored by Kevin P. Delaney

Since Specialization

Citations

This map shows the geographic impact of Kevin P. Delaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin P. Delaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin P. Delaney more than expected).

Fields of papers citing papers by Kevin P. Delaney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin P. Delaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin P. Delaney. The network helps show where Kevin P. Delaney may publish in the future.

Co-authorship network of co-authors of Kevin P. Delaney

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin P. Delaney. A scholar is included among the top collaborators of Kevin P. Delaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin P. Delaney. Kevin P. Delaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world HIV RNA and Antigen/Antibody Testing Among People Who Use Long-acting Injectable Preexposure Prophylaxis 2025 ·Clinical Infectious Diseases ·Weiming Zhu,Kevin P. Delaney,Ya-Lin A. Huang,Rupa Patel,Athena P. Kourtis,Karen W. Hoover	1
2	Trends in Sex of Sex Partners and Sexual Identity Among US Adolescents, 2015–2021 2025 ·Journal of Adolescent Health ·(unknown),(unknown),Linda J. Koenig,(unknown),Austin M. Williams,Kevin P. Delaney,Karen W. Hoover,Deven T. Hamilton,Steven M. Goodreau	0
3	Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 2025 ·MMWR Morbidity and Mortality Weekly Report ·Agam K. Rao,Faisal S. Minhaj,Rosalind J. Carter,Jonathan Duffy,Panayampalli S. Satheshkumar,Kevin P. Delaney,Laura A.S. Quilter,Rachel Kachur,Catherine McLean,Danielle Moulia,(unknown),Marie A. de Perio,Ian H. Spicknall,Beth P. Bell,Pablo J. Sánchez,Christina L. Hutson,Amanda Cohn	0
4	Suspected Mpox Symptoms and Testing in Men Who Have Sex With Men in the United States: Cross-Sectional Study 2025 ·JMIR Public Health and Surveillance ·Kaitlyn Atkins,(unknown),Amrita Rao,Travis Sanchez,(unknown),(unknown),Patrick S. Sullivan,Yasmin P. Ogale,Winston E. Abara,Kevin P. Delaney,Stefan Baral	0
5	Mpox and Vaccine Knowledge, Beliefs, and Sources of Trusted Information Among Gay, Bisexual, and Other Men Who Have Sex With Men in the U.S. 2024 ·SHILAP Revista de lepidopterología ·(unknown),Kaitlyn Atkins,Winston E. Abara,(unknown),Amy Lansky,Elizabeth DiNenno,(unknown),Kevin P. Delaney,Sarah M. Murray,Travis Sanchez,Stefan Baral	2
6	Evaluating the impact of point-of-care HIV viral load assessment on linkage to care in Baltimore, MD: a randomized controlled trial 2023 ·BMC Infectious Diseases ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Richard E. Rothman,Yu‐Hsiang Hsieh,Susan H. Eshleman,Heba H. Mostafa,(unknown),Pollyanna R. Chávez,(unknown),Kevin P. Delaney,(unknown),Robin J. MacGowan,Yukari C. Manabe,Matthew M. Hamill	1
7	Potential contribution of PrEP uptake by adolescents 15–17 years old to achieving the “Ending the HIV Epidemic” incidence reduction goals in the US South 2023 ·PLoS ONE ·Deven T. Hamilton,Li Yan Wang,Karen W. Hoover,Dawn K. Smith,Kevin P. Delaney,Jingjing Li,(unknown),Samuel M. Jenness,Steven M. Goodreau	2
8	Achieving the “Ending the HIV Epidemic in the U.S.” incidence reduction goals among at-risk populations in the South 2023 ·BMC Public Health ·Deven T. Hamilton,Karen W. Hoover,Dawn K. Smith,Kevin P. Delaney,Li Yan Wang,Jingjing Li,(unknown),Samuel M. Jenness,Steven M. Goodreau	9
9	Characteristics of Mpox Vaccine Recipients Among a Sample of Men Who Have Sex With Men With Presumed Exposure to Mpox 2023 ·Sexually Transmitted Diseases ·Winston E. Abara,Patrick F. Sullivan,(unknown),Travis Sanchez,Kaitlyn Atkins,Kevin P. Delaney,(unknown),(unknown),Stefan Baral,Yasmin P. Ogale,(unknown),Amy Lansky	5
10	Mpox Knowledge, Attitudes, and Practices Among Persons Presenting for JYNNEOS Vaccination—District of Columbia, August to October 2022 2023 ·Sexually Transmitted Diseases ·Rashida Hassan,(unknown),(unknown),Kelly Chapman,Anil T. Mangla,(unknown),Christina Willut,Michelle Lee,(unknown),Sarah Gillani,Casey E. Copen,David A. Jackson,Michelle A. Waltenburg,Kevin P. Delaney,(unknown),Christine Agnew-Brune,Lisa P. Oakley,(unknown)	3
11	The Role of HIV Partner Services in the Modern Biomedical HIV Prevention Era: A Network Modeling Study 2022 ·Sexually Transmitted Diseases ·Samuel M. Jenness,(unknown),Cynthia M. Lyles,Kyle T. Bernstein,(unknown),Eva A. Enns,Patrick S. Sullivan,Kevin P. Delaney	3
12	Distribution of HIV Self-tests by Men Who have Sex with Men (MSM) to Social Network Associates 2022 ·AIDS and Behavior ·Shilpa N. Patel,Pollyanna R. Chávez,Craig B. Borkowf,Patrick S. Sullivan,Akshay Sharma,(unknown),Kevin P. Delaney,Sabina Hirshfield,Laura G. Wesolowski,A. D. McNaghten,Robin J. MacGowan,(unknown)	3
13	Strategies Adopted by Gay, Bisexual, and Other Men Who Have Sex with Men to Prevent Monkeypox virus Transmission — United States, August 2022 2022 ·MMWR Morbidity and Mortality Weekly Report ·Kevin P. Delaney,Travis Sanchez,(unknown),(unknown),(unknown),Christine Agnew-Brune,(unknown),Rachel Kachur,Neal Carnes,Elizabeth DiNenno,Amy Lansky,Kathleen A. Ethier,Patrick S. Sullivan,Stefan Baral,Alexandra M. Oster	92
14	Racial and ethnic disparities in HIV diagnoses among heterosexually active persons in the United States nationally and by state, 2018 2021 ·PLoS ONE ·Erika G. Martin,(unknown),Rachel Hart-Malloy,Dawn K. Smith,Kevin P. Delaney,Thomas L. Gift,Andrés A. Berruti,(unknown),Eli S. Rosenberg	12
15	Impact of covid-19 on commercial laboratory testing for hiv in the United States 2021 ·Kevin P. Delaney,P Jayanthi,(unknown),(unknown),Marc A. Pitasi,Yibo Huang,Kathleen P. Hartnett,(unknown)	7
16	Modeling an integrated HIV prevention and care continuum to achieve the Ending the HIV Epidemic goals 2020 ·AIDS ·Samuel M. Jenness,Jordan A. Johnson,Karen W. Hoover,Dawn K. Smith,Kevin P. Delaney	24
17	Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010–2017 2020 ·MMWR Morbidity and Mortality Weekly Report ·Anne Harwood Peruski,Laura G. Wesolowski,Kevin P. Delaney,Pollyanna R. Chávez,S. Michele Owen,Timothy C. Granade,(unknown),William M. Switzer,Xue–Yuan Dong,John T. Brooks,M. Patricia Joyce	20
18	Development and Characterization of a Bead-Based, Multiplex Assay for Estimation of Recent HIV Type 1 Infection 2011 ·AIDS Research and Human Retroviruses ·Kelly A. Curtis,Melanie S. Kennedy,Man Charurat,Abdulsalami Nasidi,Kevin P. Delaney,Thomas J. Spira,S. Michele Owen	30
19	Evaluation of the Performance Characteristics of 6 Rapid HIV Antibody Tests 2010 ·Clinical Infectious Diseases ·Kevin P. Delaney,Bernard M. Branson,(unknown),Susan Phillips,Debra Candal,S. Michele Owen,(unknown)	110
20	Investigation of False Positive Results with an Oral Fluid Rapid HIV-1/2 Antibody Test 2007 ·PLoS ONE ·Krishna Jafa,Pragna Patel,Duncan MacKellar,Patrick S. Sullivan,Kevin P. Delaney,(unknown),Alexandra Newman,Sindy M. Paul,Evan M. Cadoff,Eugene Martin,(unknown),Bernard M. Branson,(unknown)	36

About Kevin P. Delaney

Kevin P. Delaney is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 91 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (69 papers), HIV, Drug Use, Sexual Risk (43 papers) and HIV Research and Treatment (42 papers). The work is most often cited by research in Virology (797 citations), Infectious Diseases (1.3k citations) and Epidemiology (928 citations). Kevin P. Delaney has collaborated with scholars based in United States, Uganda and Kenya. Frequent co-authors include S. Michele Owen, Elizabeth DiNenno, Laura G. Wesolowski, Bernard M. Branson, Pollyanna R. Chávez, Joseph Prejean, Marc A. Pitasi, Amy Lansky, Steven F. Ethridge and Pragna Patel. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact